{"id":"https://genegraph.clinicalgenome.org/r/32a23c64-d5c8-43ff-8969-5f73167fbf40v1.0","type":"EvidenceStrengthAssertion","dc:description":"*OTUD6B* was first reported in relation to autosomal recessive syndromic intellectual disability in 2017; this condition is also referred to as intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies (Santiago-Sim et al., PMID: 28343629). Individuals with variants in *OTUD6B*  have been reported to present with intellectual disability, speech delay, seizures, microcephaly, gross motor delay, intrauterine growth restriction, feeding difficulties, facial dysmorphism, and various, nonspecific abnormalities of the fingers/toes.  This curation includes seven predicted null variants (nonsense, frameshift, splice) from 6 probands in 4 publications (PMIDs: 28343629, 34354232, 32181568, 30364145). Additional evidence (including individuals with putative loss of function and missense variants) has been reported in the literature (PMIDs: 30364145, 35707595, 35707595, 35430327, 32924626, 31147255), but these cases were not scored as the maximum for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity appears to be loss of function. Segregation of variants with disease in multiple families also supports this gene-disease relationship (PMIDs: 28343629, 34354232). This gene-disease relationship is also supported by experimental evidence including an animal model and functional alteration studies using patient cells (PMID: 28343629). \n\nIn summary, there is definitive evidence supporting the relationship between *OTUD6B* and autosomal recessive syndromic intellectual disability. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen ID Autism GCEP on the meeting date 08/22/2024 (SOP Version 10).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/32a23c64-d5c8-43ff-8969-5f73167fbf40","GCISnapshot":"https://genegraph.clinicalgenome.org/r/3c60103c-7d9b-4dca-aa03-151130c5d6db","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/3c60103c-7d9b-4dca-aa03-151130c5d6db_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":"2024-08-22T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/3c60103c-7d9b-4dca-aa03-151130c5d6db_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":"2024-09-30T20:51:43.830Z","role":"Publisher"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3c60103c-7d9b-4dca-aa03-151130c5d6db_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3c60103c-7d9b-4dca-aa03-151130c5d6db_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/896492ea-7c96-47ff-9018-c557548024ad","type":"EvidenceLine","dc:description":"Due to non-specific phenotypes of mice and lethality, we will choose to downgrade scoring.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1c88b618-d1fa-431c-b5fa-4a48829ba8dd","type":"Finding","dc:description":"Both mice models and humans were found to have restrictions in growth and congenital heart defects.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28343629","rdfs:label":"Mouse Model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/3c60103c-7d9b-4dca-aa03-151130c5d6db_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5268da78-f9a6-4a1b-8f02-06f7a7225de5","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2224a787-933d-4b92-982a-b810f3d821db","type":"FunctionalAlteration","dc:description":"Both of the 20S and 26S complexes from PBMCs of the homozygous subject exhibited weaker fluorescence intensity than those from the heterozygous subject, indicating that chymotrypsin-like activity was reduced.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28343629","rdfs:label":"Functional Alteration Patient Cells"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/3c60103c-7d9b-4dca-aa03-151130c5d6db_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/597e9851-64b7-4909-8d05-1387651a7d8b_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c5548bb1-dfc0-4939-8630-060c631de969","type":"EvidenceLine","dc:description":"Homozygous variants also found in affected sibling within this manuscript. Parents are consanguineous. The Intellectual Disability and Autism GCEP elects to cap points at a total 2 points for individual probands. We have downgraded based on that guidance.","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c5548bb1-dfc0-4939-8630-060c631de969_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28343629","allele":{"id":"https://genegraph.clinicalgenome.org/r/13d16555-a1e3-4ec1-9b8f-e180b54698e1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_016023.5(OTUD6B):c.83-2A>G","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA16616847"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/597e9851-64b7-4909-8d05-1387651a7d8b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28343629","rdfs:label":"Santiago-Sim_Family 5_Subject_II-1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":3,"allele":{"id":"https://genegraph.clinicalgenome.org/r/13d16555-a1e3-4ec1-9b8f-e180b54698e1"},"detectionMethod":"Unclear if exome sequencing was trio analysis. Author's comment that both parents are heterozygous for variant.","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001250","obo:HP_0000750","obo:HP_0002194","obo:HP_0002650","obo:HP_0001999","obo:HP_0008897","obo:HP_0012443","obo:HP_0001252","obo:HP_0001770","obo:HP_0001249","obo:HP_0011968","obo:HP_0010864","obo:HP_0000252"],"previousTesting":false,"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/c5548bb1-dfc0-4939-8630-060c631de969_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/0c1c5f1d-7494-4f15-8a0e-5add969932eb_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7af0245d-a081-4141-ab73-e68694caaf47","type":"EvidenceLine","dc:description":"There is no family history of consanguinity. The ZIMZ1 gene is found to be associated with autosomal dominant neurodevelopmental disorder with dysmorphic facies and distal skeletal anomalies. This gene was curated in 2022 by ClinGen as definitive, therefore we will award no points for this proband. ","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7af0245d-a081-4141-ab73-e68694caaf47_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34680978","allele":{"id":"https://genegraph.clinicalgenome.org/r/ce36ef64-de75-44c5-a568-16cad65b74a0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_016023.5(OTUD6B):c.783del (p.Lys261AsnfsTer3)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA4804844"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/0c1c5f1d-7494-4f15-8a0e-5add969932eb","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34680978","rdfs:label":"Phetthong_Patient","ageType":"AgeAtReport","ageUnit":"Years","ageValue":5,"allele":{"id":"https://genegraph.clinicalgenome.org/r/ce36ef64-de75-44c5-a568-16cad65b74a0"},"detectionMethod":"The CMA showed a paternally inherited 0.118 Mb deletion of 8q21.3, chr8:92084087â€“92202189, with OTUD6B and LRRC69 involved. Parental studies found the deletion was paternally inherited. Singleton WES was performed and identified another variant in OTUD6B and a heterozygous substitution at the splice donor site of intron 14 of the ZMIZ1 gene, c.491 + 2T > C. It was determined that the patient's father is also heterozygous for the ZMIZ1 gene variant while mother is homozygous wild type. The mother is heterozygous for OTUD6B variant and father is heterozygous for deletion including OTUD6B. Patient's father is asymptomatic but we will still choose not to score due to ZMIZ1 gene variant.","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0000750","obo:HP_0002194","obo:HP_0001250","obo:HP_0001999","obo:HP_0011304","obo:HP_0001249","obo:HP_0011968","obo:HP_0001627"],"previousTesting":true,"previousTestingDescription":"Karyotype and FISH analysis of 7q11.23, which demonstrated 46,XX and no deletion observed by FISH.","secondTestingMethod":"Chromosomal microarray","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/7af0245d-a081-4141-ab73-e68694caaf47_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/ffc7d8a3-b72f-4081-8c09-045c095c4f20_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0e729b50-5a38-4c71-bce5-6683c04f094f","type":"EvidenceLine","dc:description":"Parents are consangiunous. The variant is a recurrent variant identified in 2 additional families within this manuscript and 2 families reported in other publications (PMID:32924626, PMID:31147255). The Intellectual Disability and Autism GCEP elects to cap points at a total 2 points for individual probands. We have downgraded here based on that guidance.","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0e729b50-5a38-4c71-bce5-6683c04f094f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28343629","allele":{"id":"https://genegraph.clinicalgenome.org/r/e4ee1d1e-522e-4745-a590-c731bdfc6cd7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_016023.5(OTUD6B):c.343C>T (p.Arg115Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA4804760"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/ffc7d8a3-b72f-4081-8c09-045c095c4f20","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28343629","rdfs:label":"Santiago-Sim_Family 3_Subject_II-2","ageType":"AgeAtReport","ageUnit":"Years","ageValue":13,"allele":{"id":"https://genegraph.clinicalgenome.org/r/e4ee1d1e-522e-4745-a590-c731bdfc6cd7"},"detectionMethod":"Authors noted exome sequencing was performed though they do not comment if it was trio or proband only sequencing. It is unclear if exome was performed on all affected siblings or if targeted testing was used.","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001627","obo:HP_0010864","obo:HP_0011304","obo:HP_0000252","obo:HP_0001999","obo:HP_0001250","obo:HP_0002194","obo:HP_0001249","obo:HP_0001511","obo:HP_0012443","obo:HP_0002650","obo:HP_0000750","obo:HP_0011968","obo:HP_0001252","obo:HP_0008897"],"previousTesting":false,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/0e729b50-5a38-4c71-bce5-6683c04f094f_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/0d538d46-fda5-46e0-ab1f-a919892390e1_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4d5557ea-437a-4115-aa69-e4dd2d2d774e","type":"EvidenceLine","dc:description":"Parents are consanguineous. The Intellectual Disability and Autism GCEP elects to cap points at a total 2 points for individual probands. We have downgraded here based on that guidance.","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4d5557ea-437a-4115-aa69-e4dd2d2d774e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32181568","allele":{"id":"https://genegraph.clinicalgenome.org/r/3865a265-b694-4593-9ce1-9074a843271d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_016023.5(OTUD6B):c.631G>T (p.Glu211Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA4804812"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/0d538d46-fda5-46e0-ab1f-a919892390e1","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32181568","rdfs:label":"Alkuraya_Patient","ageType":"AgeAtReport","ageUnit":"Months","ageValue":10,"allele":{"id":"https://genegraph.clinicalgenome.org/r/3865a265-b694-4593-9ce1-9074a843271d"},"detectionMethod":"Unclear if exome sequencing was trio analysis. Variant status of parents was not noted.","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001770","obo:HP_0008897","obo:HP_0001999","obo:HP_0000252","obo:HP_0011968","obo:HP_0001627","obo:HP_0001511","obo:HP_0002194","obo:HP_0011304"],"previousTesting":false,"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/4d5557ea-437a-4115-aa69-e4dd2d2d774e_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/8baf0b16-79a0-4475-b5e5-eafa2d93d4c7_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8220b81c-e2a4-4462-8a5d-335ec3faa369","type":"EvidenceLine","dc:description":"The homozygous variants were also seen in the affected sibling of the proband within the manuscript. Parents are consanguineous. The Intellectual Disability and Autism GCEP elects to cap points at a total 2 points for individual probands. We have downgraded here based on that guidance.","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8220b81c-e2a4-4462-8a5d-335ec3faa369_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Proteosome complexes were separated on non-denaturing PAGE and showed decreased chymotrypsin-like activity. Data showed deletion associated with a 26S proteasome assembly defect.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/8220b81c-e2a4-4462-8a5d-335ec3faa369_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28343629","allele":{"id":"https://genegraph.clinicalgenome.org/r/3e2bbe69-d5c5-4deb-9408-dc712c4e4d1d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_016023.5(OTUD6B):c.379_383del (p.Leu127ArgfsTer8)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA4804766"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/8baf0b16-79a0-4475-b5e5-eafa2d93d4c7","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28343629","rdfs:label":"Santiago-Sim_Family 4_Subject_II-3","ageType":"AgeAtReport","ageUnit":"Years","ageValue":9,"allele":{"id":"https://genegraph.clinicalgenome.org/r/3e2bbe69-d5c5-4deb-9408-dc712c4e4d1d"},"detectionMethod":"Unclear if exome sequencing was trio analysis. Authors comment that both parents are heterozygous for variant.","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0000750","obo:HP_0011304","obo:HP_0001511","obo:HP_0001212","obo:HP_0001252","obo:HP_0002194","obo:HP_0001249","obo:HP_0001250","obo:HP_0011968","obo:HP_0008897","obo:HP_0010864","obo:HP_0000252","obo:HP_0001999"],"previousTesting":false,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/8220b81c-e2a4-4462-8a5d-335ec3faa369_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/3c60103c-7d9b-4dca-aa03-151130c5d6db_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ac66c20d-05d4-4483-a52e-48e4f83bc336_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28343629","rdfs:label":"Santiago-Sim_Family 3","estimatedLodScore":1.2,"family":{"id":"https://genegraph.clinicalgenome.org/r/ac66c20d-05d4-4483-a52e-48e4f83bc336","type":"Family","rdfs:label":"Santiago-Sim_Family 3","member":{"id":"https://genegraph.clinicalgenome.org/r/ffc7d8a3-b72f-4081-8c09-045c095c4f20"}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":3,"proband":{"id":"https://genegraph.clinicalgenome.org/r/ffc7d8a3-b72f-4081-8c09-045c095c4f20"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/2805058b-60af-414f-99a4-8b92a3baa34c_family_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34354232","rdfs:label":"Abdel-Salam_Family II","family":{"id":"https://genegraph.clinicalgenome.org/r/2805058b-60af-414f-99a4-8b92a3baa34c","type":"Family","rdfs:label":"Abdel-Salam_Family II"},"phenotypePositiveAllelePositive":3},{"id":"https://genegraph.clinicalgenome.org/r/40905b82-0260-4b92-a73d-501cef2782b7_family_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28343629","rdfs:label":"Santiago-Sim_Family 6","estimatedLodScore":1.2,"family":{"id":"https://genegraph.clinicalgenome.org/r/40905b82-0260-4b92-a73d-501cef2782b7","type":"Family","rdfs:label":"Santiago-Sim_Family 6"},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":3,"sequencingMethod":{"id":"cg:AllGenesSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/d708337a-275d-4e04-aff2-0a6d3c41d961_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/78de83b2-eba4-49cb-b695-891b794085da","type":"EvidenceLine","dc:description":"Parents are not consanguineous. The intellectual disability and autism GCEP elects to cap points at a total 2 points for individual probands. We have downgraded here based on that guidance.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/78de83b2-eba4-49cb-b695-891b794085da_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Variant was evaluated using agarose gel from the RNA from parents, proband, and control. The results showed that variant causes skipping of exon 2 and introduces a premature stop codon 6 amino acids downstream. The alternative transcript is believed to be degraded by the nonsense-mediated mRNA decay mechanism.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/78de83b2-eba4-49cb-b695-891b794085da_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30364145","allele":{"id":"https://genegraph.clinicalgenome.org/r/c532bb7c-8774-4a82-bb0e-4d2c9f2cf8f1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_016023.5(OTUD6B):c.234+1G>C","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA4804708"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/d573607b-6ea0-405c-94e8-abfe52c03b24","type":"EvidenceLine","dc:description":"The Intellectual Disability and Autism GCEP elects to cap points at a total 2 points for individual probands. We have downgraded here based on that guidance.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d573607b-6ea0-405c-94e8-abfe52c03b24_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"An agarose gel was performed on RNA extracted from peripheral blood mononuclear cells of the patient, parents and control. RT-PCR was also performed on the mother's and proband's RNA. These showed that the splicing event was exon-3 skipping but also included a second aberrant transcript corresponding to the inclusion of part of intron 3 due to activation of a cryptic donor splice site. This produces an incomplete protein lacking a portion of the N-terminal coiled-coil domain.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/d573607b-6ea0-405c-94e8-abfe52c03b24_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30364145","allele":{"id":"https://genegraph.clinicalgenome.org/r/1ec0d6de-bf72-40b8-93dc-e493e716a5c8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_016023.5(OTUD6B):c.315+1G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA4804736"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/d708337a-275d-4e04-aff2-0a6d3c41d961","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30364145","rdfs:label":"Straniero_II2","ageType":"AgeAtReport","ageUnit":"Years","ageValue":6,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/c532bb7c-8774-4a82-bb0e-4d2c9f2cf8f1"},{"id":"https://genegraph.clinicalgenome.org/r/1ec0d6de-bf72-40b8-93dc-e493e716a5c8"}],"detectionMethod":"Proband underwent singleton exome. Follow up testing confirmed each parent was heterozygous for a different OTUD6B variant.","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0011968","obo:HP_0001999","obo:HP_0001212","obo:HP_0011304","obo:HP_0001627","obo:HP_0001250","obo:HP_0000252","obo:HP_0001511","obo:HP_0001249","obo:HP_0000750","obo:HP_0001256"],"previousTesting":true,"previousTestingDescription":"Underwent Rubinstein-Taybi syndrome testing, KDM6A and KMT2D/MLL2 gene testing, whole-genome CGH-array analysis, and FISH. No genetic abnormalities were detected. Also underwent 108 gene epilepsy panel that also did not reveal a variant with known pathogenic significance. ","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/d573607b-6ea0-405c-94e8-abfe52c03b24_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/78de83b2-eba4-49cb-b695-891b794085da_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/ae75f932-d387-4f2e-89ff-7957c73fa942_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a9f48f50-f476-4a77-aeb5-2b17ea1c64aa","type":"EvidenceLine","dc:description":"Homozygous variants are also seen in an affected sibling in the same manuscript. Parents and great grandparents are consanguineous. The Intellectual Disability and Autism GCEP elects to cap points at a total 2 points for individual probands. We have downgraded here based on that guidance.","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a9f48f50-f476-4a77-aeb5-2b17ea1c64aa_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34354232","allele":{"id":"https://genegraph.clinicalgenome.org/r/34622e85-0378-4ca1-b73c-af0805345083","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_016023.5(OTUD6B):c.181C>T (p.Gln61Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA371658134"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/ae75f932-d387-4f2e-89ff-7957c73fa942","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34354232","rdfs:label":"Abdel-Salam_Patient I.1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":9,"allele":{"id":"https://genegraph.clinicalgenome.org/r/34622e85-0378-4ca1-b73c-af0805345083"},"detectionMethod":"Unclear if exome sequencing was trio analysis. Author's comment that both parents are heterozygous for variant.","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0000252","obo:HP_0001999","obo:HP_0001249","obo:HP_0001250","obo:HP_0011968","obo:HP_0011304","obo:HP_0002194","obo:HP_0010864","obo:HP_0012443","obo:HP_0000750"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/a9f48f50-f476-4a77-aeb5-2b17ea1c64aa_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":9077,"specifiedBy":"GeneValidityCriteria10","strengthScore":14,"subject":{"id":"https://genegraph.clinicalgenome.org/r/IyMub8_pl9w","type":"GeneValidityProposition","disease":"obo:MONDO_0000508","gene":"hgnc:24281","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_3c60103c-7d9b-4dca-aa03-151130c5d6db-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}